对持续抗抑郁作用的新视角:重点关注调节突触可塑性的神经素
Yuan Ruan1,2, Ruolan Yuan1,2, Jiaqi He1,2
1Tianjin University of Traditional Chinese Medicine, Tianjin, PR China.
Cell death discovery
|May 1, 2024
概括
由于目前的药物限制,需要持续的抗抑郁药物策略. 神经素调节突触可塑性,为开发新的长期抑郁症治疗提供了一个有希望的目标.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 抑郁症是一个全球性的健康问题,治疗效果有限.
- 现有的抗抑郁药往往具有较低的反应率和短期影响.
- 伴随性精神疾病使抑郁症的管理变得复杂,需要持续的策略.
研究的目的:
- 探索持续抗抑郁作用的新型治疗点.
- 调查突触可塑性在长期抗抑郁药作用中的作用.
- 突出神经素作为关键调节剂,将突触可塑性与抗抑郁药的结果联系起来.
主要方法:
- 关于胺, псилоцибин以及它们对突触可塑性的影响的最新研究的综述.
- 对神经激素在调节突触可塑性方面的功能进行分析.
- 检查神经素介导机制,包括蛋白质水平,剪接,表观遗传学和星系相互作用.
主要成果:
- 突触可塑性对于持续的抗抑郁药效果至关重要.
- 神经素被确定为突触可塑性和持续抗抑郁作用之间的关键调解者.
- 多种与神经素相关的机制有助于调节突触可塑性.
结论:
- 通过神经激素调节突触可塑性是持续抗抑郁药物开发的有希望的途径.
- 针对神经素提供了一种新的策略,以解决抑郁症治疗的未满足需求.
- 对神经素的进一步研究具有很大的潜力,可以促进我们对抑郁症的理解和治疗.
相关概念视频
Long-term Depression
30.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.8K
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Long-term Potentiation
2.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Neurochemical Transmission: Sites of Drug Action
2.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.3K


